A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma

Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/00002371-200407000-00001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search